Skip to main content
Equibles
INVA logo

INVA · Innoviva, Inc.

Track INVA — free

Use INVA with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.35 +0.27 (+1.28%)
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.52B
Shares
72.25M

INVA metrics

76 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$21.08
Market cap
$1.52B

Price action

19 metrics
Price change (1W)
-0.4%
Price change (30D)
+1.5%
Price change (3M)
-1.3%
Price change (6M)
-5.5%
Price change (YTD)
+5.5%
Price change (1Y)
+3.2%
Trailing year
Price change (5Y)
+37.7%
52-week high
$24.24
52-week low
$16.67
Change from 52-week high
-13.0%
Change from 52-week low
+26.5%
Annualized volatility
28.3%
Beta
-0.1
RSI (14D)
48.6
Price vs SMA 50
-2.4%
Price vs SMA 200
-3.3%
Avg volume (3M)
771,489
Relative volume
1.0
Average dollar volume
$16.89M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
72.25M

Valuation

12 metrics
P / E (TTM)
4.8
Trailing earnings · reciprocal yield 20.6%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.5×
reciprocal yield 28.9%
P / book
1.2
reciprocal yield 81.0%
FCF yield
12.4%
TTM · current market cap
Buyback yield
3.7%
P / FCF
8.0
reciprocal yield 12.4%
P / operating cash flow
8.0
reciprocal yield 12.6%
Earnings yield
23.5%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
5.2×
reciprocal yield 19.2%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-05-08

Profitability

9 metrics
Gross margin
72.2%
Operating margin
36.9%
Trailing 12 months
Net margin
81.2%
Gross profit (TTM)
$317.65M
Operating profit (TTM)
$162.57M
Net income (TTM)
$357.24M
Trailing 12 months
Diluted EPS (TTM)
$4.35
FCF margin
43.1%
Effective tax rate
14.8%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+19.3%
Year over year
Net income growth YoY
-231.0%
Revenue (TTM)
$440.00M
Trailing 12 months
EPS growth YoY
-248.1%
Shares change YoY
-13.1%
Year over year · fewer shares
Revenue CAGR (3Y)
+7.5%
Revenue CAGR (5Y)
+4.1%
EPS CAGR (3Y)
+11.7%
EPS CAGR (5Y)
+10.3%
FCF CAGR (3Y)
-1.0%
FCF CAGR (5Y)
-9.0%

Quality

14 metrics
Return on equity
29.0%
Return on assets
21.0%
Debt / equity
—
Current ratio
16.0
EBITDA (TTM)
$373.37M
Free cash flow (TTM)
$189.44M
Quick ratio
15.2
Interest coverage
8.9
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$570.39M
Total assets
$1.70B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$191.49M
Capital expenditures (TTM)
$2.05M
R&D (TTM)
$28.66M
SG&A (TTM)
$126.42M
Stock compensation (TTM)
$12.19M
R&D / revenue
6.5%
Stock compensation / revenue
2.8%

Ownership (13F)

3 metrics
13F filers
307
13F filer change QoQ
+21
Institutional ownership
103.6%

Short interest

3 metrics
Short interest
9.5%
Latest settlement · 9.2 days to cover
Days to cover
9.2d
Short-squeeze score
68 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1080014 CUSIP 45781M101 13F (30d) 234 filings 234 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)